APM looks to have a small bounce backAPM seems to gain some reversal volume as all the support levels are smashed and the stock is making a bounce back.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.82 M USD
431.38 K USD
2.17 M
About Aptorum Group Limited
Sector
CEO
Ian Huen
Headquarters
London
Website
Founded
2010
FIGI
BBG00LX0JFQ4
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
$APM Target PTs 7-14 Long term PT 30 and higherAptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer
The FDA has granted Orphan Drug Designation to Aptorum Group Limited (NASDAQ: APM) SACT-1, a repurposed small molecule compound for Neuroblastoma.
Aptorum Group plans to file an Investigational New Drug Appl
APM 1Dtest
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company
APM: Descending triangle, confirmedDescending triangle, Confirmed
Pros
Descending volume
Volume spike on break out
PPS under 50MA
No data on 200MA
No data on 250MA
RS below 0 and descending
Overall bearish
No support under 1,37$
Price Target
PT1 = 2,11 (filled)
PT2 = 1,37
Could see lower
touch the resistance and have the potential to rise.touch the resistance and have the potential to rise.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APM is 0.6700 USD — it has increased by 0.68% in the past 24 hours. Watch Aptorum Group Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aptorum Group Limited stocks are traded under the ticker APM.
APM stock has fallen by −39.17% compared to the previous week, the month change is a −57.70% fall, over the last year Aptorum Group Limited has showed a −50.74% decrease.
APM stock is 13.23% volatile and has beta coefficient of −0.40. Track Aptorum Group Limited stock price on the chart and check out the list of the most volatile stocks — is Aptorum Group Limited there?
Today Aptorum Group Limited has the market capitalization of 3.81 M, it has decreased by −33.09% over the last week.
Yes, you can track Aptorum Group Limited financials in yearly and quarterly reports right on TradingView.
Aptorum Group Limited is going to release the next earnings report on Apr 21, 2025. Keep track of upcoming events with our Earnings Calendar.
No, APM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 3.00 employees. See our rating of the largest employees — is Aptorum Group Limited on this list?
Like other stocks, APM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptorum Group Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptorum Group Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptorum Group Limited stock shows the sell signal. See more of Aptorum Group Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.